Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$37.11 - $50.69 $241,103 - $329,332
-6,497 Reduced 14.48%
38,361 $1.85 Million
Q1 2024

May 03, 2024

BUY
$40.65 - $65.76 $26,991 - $43,664
664 Added 1.5%
44,858 $2.15 Million
Q4 2023

Feb 08, 2024

BUY
$48.3 - $68.06 $41,634 - $58,667
862 Added 1.99%
44,194 $2.87 Million
Q3 2023

Nov 09, 2023

SELL
$54.2 - $71.67 $105,906 - $140,043
-1,954 Reduced 4.31%
43,332 $2.83 Million
Q2 2023

Aug 07, 2023

BUY
$56.23 - $71.17 $111,391 - $140,987
1,981 Added 4.57%
45,286 $2.63 Million
Q1 2023

May 01, 2023

BUY
$53.43 - $68.12 $579,288 - $738,557
10,842 Added 33.4%
43,305 $2.67 Million
Q4 2022

Feb 07, 2023

SELL
$61.23 - $83.62 $128,460 - $175,434
-2,098 Reduced 6.07%
32,463 $2.06 Million
Q3 2022

Oct 25, 2022

BUY
$65.58 - $84.69 $654,947 - $845,799
9,987 Added 40.64%
34,561 $2.51 Million
Q2 2022

Aug 08, 2022

BUY
$52.13 - $93.81 $1.28 Million - $2.31 Million
24,574 New
24,574 $1.67 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.96B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.